Market revenue in 2023 | USD 297.8 million |
Market revenue in 2030 | USD 489.5 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Device |
Fastest growing segment | Software |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Software, Device, Storage Systems |
Key market players worldwide | Danaher Corp, Hamamatsu Photonics KK, Koninklijke Philips NV, Olympus Corp, Roche Holding AG ADR, McCormick & Co Inc Registered Shs Non Vtg, Inspire Medical Systems Inc, PHC Holdings Corp, Huron Consulting Group Inc, CellaVision AB Bearer Shs, IBEX Ltd, Morphic Holding Inc, Nuvation Bio Inc Ordinary Shares - Class A |
Device was the largest segment with a revenue share of 50.97% in 2023. Horizon Databook has segmented the Europe digital pathology market based on software, device, storage systems covering the revenue growth of each sub-segment from 2018 to 2030.
The European Digital Pathology market followed North America in terms of revenue share in 2016 and is expected to remain unaltered till 2025. The size of the market is justified by contribution from developed European economies such as Germany and the UK.
The presence of government initiatives for continued R&D in digital pathology is another key factor that drives the growth of this market. The European Institute of Biomedical Imaging Research has invested more than USD 66.84 million for biomedical imaging research over the past decade.
Furthermore, The European region has gained momentum for digital pathology due to growing geriatric population base resulting in increasing adoption of digital pathology in European countries and successful implementation of pathology projects in this region.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account